Trichomegaly of the Eyelashes After Lung Cancer Treatment with the Epidermal Growth Factor Receptor Inhibitor ErlotinibBRAITEH, Fadi; KURZROCK, Razelle; JOHNSON, Faye M et al.Journal of clinical oncology. 2008, Vol 26, Num 20, pp 3460-3462, issn 0732-183X, 3 p.Article

Abrogation of signal transducer and activator of transcription 3 reactivation after src kinase inhibition results in synergistic antitumor effectsJOHNSON, Faye M; SAIGAL, Babita; TRAN, Hai et al.Clinical cancer research. 2007, Vol 13, Num 14, pp 4233-4244, issn 1078-0432, 12 p.Article

Dasatinib (BMS-354825) tyrosine kinase inhibitor suppresses invasion and induces cell cycle arrest and apoptosis of head and neck squamous cell carcinoma and non-small cell lung cancer cellsJOHNSON, Faye M; SAIGAL, Babita; TALPAZ, Moshe et al.Clinical cancer research. 2005, Vol 11, Num 19, pp 6924-6932, issn 1078-0432, 9 p., 1Article

STAT5A-Mediated SOCS2 Expression Regulates Jak2 and STAT3 Activity Following c-Src Inhibition in Head and Neck Squamous CarcinomaSEN, Banibrata; SHAOHUA PENG; WOODS, Denise M et al.Clinical cancer research (Print). 2012, Vol 18, Num 1, pp 127-139, issn 1078-0432, 13 p.Article

Phase II Study of Dasatinib in Patients With Advanced Non-Small-Cell Lung CancerJOHNSON, Faye M; NEBIYOU BEKELE, B; LIPPMAN, Scott M et al.Journal of clinical oncology. 2010, Vol 28, Num 30, pp 4609-4615, issn 0732-183X, 7 p.Article

Weekly Alternating Therapy With Irinotecan Plus Cisplatin and Etoposide Plus Cisplatin in the Treatment of Patients With Extensive Small Cell Lung CarcinomaWILLIAM, William N; UYEKI, James; JOHNSON, Faye M et al.Cancer. 2010, Vol 116, Num 10, pp 2409-2415, issn 0008-543X, 7 p.Article

Combating Resistance to Anti-IGFR Antibody by Targeting the Integrin β3-Src PathwayDONG HOON SHIN; LEE, Hyo-Jong; LEE, Ho-Young et al.Journal of the National Cancer Institute. 2013, Vol 105, Num 20, pp 1558-1570, issn 0027-8874, 13 p.Article

Phase II Study of the Anti―Insulin-Like Growth Factor Type 1 Receptor Antibody CP-751,871 in Combination With Paclitaxel and Carboplatin in Previously Untreated, Locally Advanced, or Metastatic Non―Small-Cell Lung CancerKARP, Daniel D; PAZ-ARES, Luis G; JOHNSON, Faye M et al.Journal of clinical oncology. 2009, Vol 27, Num 15, pp 2516-2522, issn 0732-183X, 7 p.Article

Expression of the Receptor Tyrosine Kinase EphA2 Is Increased in Smokers and Predicts Poor Survival in Non-Small Cell Lung CancerBRANNAN, Jennifer M; WENLI DONG; PRUDKIN, Ludmila et al.Clinical cancer research (Print). 2009, Vol 15, Num 13, pp 4423-4430, issn 1078-0432, 8 p.Article

Epithelial to Mesenchymal Transition in Head and Neck Squamous Carcinoma : Association of Src Activation With E-cadherin Down-regulation, Vimentin Expression, and Aggressive Tumor FeaturesMANDAL, Mahitosh; MYERS, Jeffery N; EL-NAGGAR, Adel K et al.Cancer. 2008, Vol 112, Num 9, pp 2088-2100, issn 0008-543X, 13 p.Article

Phase I studies of imatinib mesylate combined with cisplatin and irinotecan in patients with small cell lung carcinomaJOHNSON, Faye M; KRUG, Lee M; TRAN, Hai T et al.Cancer. 2006, Vol 106, Num 2, pp 366-374, issn 0008-543X, 9 p.Article

Uncommon Epidermal Growth Factor Receptor mutations in non-small cell lung cancer and their mechanisms of EGFR tyrosine kinase inhibitors sensitivity and resistanceMASSARELLI, Erminia; JOHNSON, Faye M; ERICKSON, Heidi S et al.Lung cancer. 2013, Vol 80, Num 3, pp 235-241, issn 0169-5002, 7 p.Article

Phase 1 Pharmacokinetic and Drug-Interaction Study of Dasatinib in Patients With Advanced Solid TumorsJOHNSON, Faye M; AGRAWAL, Shruti; CHIAPPORI, Alberto A et al.Cancer. 2010, Vol 116, Num 6, pp 1582-1591, issn 0008-543X, 10 p.Article

Distinct Interactions Between c-Src and c-Met in Mediating Resistance to c-Src Inhibition in Head and Neck CancerSEN, Banibrata; SHAOHUA PENG; SAIGAL, Babita et al.Clinical cancer research (Print). 2011, Vol 17, Num 3, pp 514-524, issn 1078-0432, 11 p.Article

Sustained Src Inhibition Results in Signal Transducer and Activator of Transcription 3 (STAT3) Activation and Cancer Cell Survival via Altered Janus-Activated Kinase―TAT3 BindingSEN, Banibrata; SAIGAL, Babita; PARIKH, Nila et al.Cancer research (Chicago, Ill.). 2009, Vol 69, Num 5, pp 1958-1965, issn 0008-5472, 8 p.Article

Src-family kinases are activated in non-small cell lung cancer and promote the survival of epidermal growth factor receptor-dependent cell linesJIE ZHANG; KALYANKRISHNA, Shailaja; WISLEZ, Marie et al.The American journal of pathology. 2007, Vol 170, Num 1, pp 366-376, issn 0002-9440, 11 p.Article

A Phase II study of docetaxel and carboplatin as neoadjuvant therapy for nasopharyngeal carcinoma with early T status and advanced N statusJOHNSON, Faye M; GARDEN, Adam; GLISSON, Bonnie S et al.Cancer. 2004, Vol 100, Num 5, pp 991-998, issn 0008-543X, 8 p.Article